Conotruncal anomalies in the trisomy 16 mouse: an immunohistochemical analysis with emphasis on the involvement of the neural crest.
The trisomy 16 (Ts16) mouse is generally considered a model for human Down's syndrome (trisomy 21). However, many of the cardiac defects in the Ts16 mouse do not reflect the heart malformations seen in patients suffering from this chromosomal disorder. In this study we describe the conotruncal malformations in mice with trisomy 16. The development of the outflow tract was immunohistochemically studied in serially sectioned hearts from 34 normal and 26 Ts16 mouse embryos ranging from 8.5 to 14.5 embryonic days. Conotruncal malformations observed in the Ts 16 embryos included double outlet right ventricle, persistent truncus arteriosus, Tetralogy of Fallot, and right-sided aortic arch. This spectrum of malformations is remarkably similar to that seen in humans suffering from DiGeorge syndrome (DGS). As perturbation of neural crest development has been proposed in the pathogenesis of DGS we specifically focussed on the fate of neural crest derived cells during outflow tract development of the Ts16 mouse using an antibody that enabled us to trace these cells during development. Severe perturbation of the neural crest-derived cell population was observed in each trisomic specimen. The abnormalities pertained to: 1) the size of the columns of neural crest-derived cells (or prongs); 2) the spatial orientation of these prongs within the mesenchymal tissues of the outflow tract; and 3) the location in which the neural crest cells interact with the myocardium. The latter abnormality appeared to be responsible for ectopic myocardialization found in trisomic embryos. Our observations strongly suggest that abnormal neural crest cell behavior is involved in the pathogenesis of the conotruncal malformations in the Ts16 mouse.
Waller
B R
BR
Department of Cell Biology & Anatomy, Cardiovascular Developmental Biology Center, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
McQuinn
T
T
Phelps
A L
AL
Markwald
R R
RR
Lo
C W
CW
Thompson
R P
RP
Wessels
A
A
D000818:Animals; D018031:Connexin 43 / Q000032:analysis; D004062:DiGeorge Syndrome / Q000196:embryology / Q000209:etiology / Q000473:pathology; D004195:Disease Models, Animal; D004314:Down Syndrome / Q000209:etiology / Q000473:pathology; D005260:Female; D019084:Fluorescent Antibody Technique, Indirect; D006330:Heart Defects, Congenital / Q000196:embryology* / Q000209:etiology / Q000473:pathology; D006352:Heart Ventricles / Q000002:abnormalities; D007621:Karyotyping; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D009432:Neural Crest / Q000002:abnormalities* / Q000737:chemistry / Q000473:pathology; D011247:Pregnancy; D014314:Trisomy; D015017:Yolk Sac / Q000166:cytology
D018031:Connexin 43